Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

RelB (phospho Ser552) rabbit pAb

Caution: Was originally (PubMed: 1577270) thought to inhibit the transcriptional activity of nuclear factor NF-kappa-B. Domain: Both N- and C-terminal domains are required for transcriptional activation. function: NF-kappa-B is a pleiotropic transcription factor which is present in almost all cell types and is involved in many biological processed such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52. The dimers bind at kappa-B sites in the DNA of their target genes and the individual dimers have distinct preferences for different kappa-B sites that they can bind with distinguishable affinity and specificity. Different dimer combinations act as transcriptional activators or repressors, respectively. NF-kappa-B is controlled by various mechanisms of post-translational modification and subcellular compartmentalization as well as by interactions with other cofactors or corepressors. NF-kappa-B complexes are held in the cytoplasm in an inactive state complexed with members of the NF-kappa-B inhibitor (I-kappa-B) family. In a conventional activation pathway, I-kappa-B is phosphorylated by I-kappa-B kinases (IKKs) in response to different activators, subsequently degraded thus liberating the active NF-kappa-B complex which translocates to the nucleus. NF-kappa-B heterodimeric RelB-p50 and RelB-p52 complexes are transcriptional activators. RELB neither associates with DNA nor with RELA/p65 or REL. Stimulates promoter activity in the presence of NFKB2/p49. induction: By mitogens. PTM: Phosphorylation at 'Thr-103' and 'Ser-573' is followed by proteasomal degradation. similarity: Contains 1 RHD (Rel-like) domain. subunit: Component of the NF-kappa-B RelB-p50 complex. Component of the NF-kappa-B RelB-p52 complex. Self-associates; the interaction seems to be transient and may prevent degradation allowing for heterodimer formation with p50 or p52. Interacts with NFKB1/p50, NFKB2/p52 and NFKB2/p100. Interacts with NFKBID.

Product Specifications

Background

Caution:Was originally (PubMed:1577270) thought to inhibit the transcriptional activity of nuclear factor NF-kappa-B., domain:Both N- and C-terminal domains are required for transcriptional activation., function:NF-kappa-B is a pleiotropic transcription factor which is present in almost all cell types and is involved in many biological processed such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52. The dimers bind at kappa-B sites in the DNA of their target genes and the individual dimers have distinct preferences for different kappa-B sites that they can bind with distinguishable affinity and specificity. Different dimer combinations act as transcriptional activators or repressors, respectively. NF-kappa-B is controlled by various mechanisms of post-translational modification and subcellular compartmentalization as well as by interactions with other cofactors or corepressors. NF-kappa-B complexes are held in the cytoplasm in an inactive state complexed with members of the NF-kappa-B inhibitor (I-kappa-B) family. In a conventional activation pathway, I-kappa-B is phosphorylated by I-kappa-B kinases (IKKs) in response to different activators, subsequently degraded thus liberating the active NF-kappa-B complex which translocates to the nucleus. NF-kappa-B heterodimeric RelB-p50 and RelB-p52 complexes are transcriptional activators. RELB neither associates with DNA nor with RELA/p65 or REL. Stimulates promoter activity in the presence of NFKB2/p49., induction:By mitogens., PTM:Phosphorylation at 'Thr-103' and 'Ser-573' is followed by proteasomal degradation., similarity:Contains 1 RHD (Rel-like) domain., subunit:Component of the NF-kappa-B RelB-p50 complex. Component of the NF-kappa-B RelB-p52 complex. Self-associates; the interaction seems to be transient and may prevent degradation allowing for heterodimer formation with p50 or p52. Interacts with NFKB1/p50, NFKB2/p52 and NFKB2/p100. Interacts with NFKBID.

UniProt

Q01201

Swiss Prot

Q01201

Reactivity

Human; Mouse

Immunogen

The antiserum was produced against synthesized peptide derived from human RelB around the phosphorylation site of Ser552. AA range:530-579

Clonality

Polyclonal

Source

Rabbit

Applications

WB; IHC; IF; ELISA

Concentration

1 mg/ml

Dilution

Western Blot: 1/500 - 1/2000. Immunohistochemistry: 1/100 - 1/300. ELISA: 1/20000. Not yet tested in other applications.

Molecular Weight

62kD

Storage Conditions

-20°C/1 year

Product Datasheet

https://www.elkbiotech.com/upload/file/Antibodies/pAb/ES7027-1.pdf

Observed Molecular Weight

62kD

Fragment

IgG

Subcellular Location

Nucleus . Cytoplasm, cytoskeleton, microtubule organizing center, centrosome . Colocalizes with NEK6 in the centrosome.

Other Product Names

RELB; Transcription factor RelB; I-Rel

Gene ID (Human)

5971

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

Rat Monoclonal IL-10 R beta Antibody (547324) [PE/Atto594]
FAB53681PEATT594 0.1 mL

Rat Monoclonal IL-10 R beta Antibody (547324) [PE/Atto594]

Ask
View Details
Rabbit Monoclonal FoxP4 Antibody (RAB-S40) [Janelia Fluor 525]
NBP3-20153JF525 0.1 mL

Rabbit Monoclonal FoxP4 Antibody (RAB-S40) [Janelia Fluor 525]

Ask
View Details
NVP-AUY922
sc-364551C 250 mg

NVP-AUY922

Ask
View Details
Glycoprotein A33 (GPA33) Antibody
abx210838-01 50 µL

Glycoprotein A33 (GPA33) Antibody

Ask
View Details
Glycoprotein A33 (GPA33) Antibody
abx210838-02 100 µL

Glycoprotein A33 (GPA33) Antibody

Ask
View Details
B3GNT5 antibody
FNab00769 100 µg

B3GNT5 antibody

Ask
View Details